Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).
Gökbuget N, Hoelzer D, Arnold R, Böhme A, Bartram CR, Freund M, Ganser A, Kneba M, Langer W, Lipp T, Ludwig WD, Maschmeyer G, Rieder H, Thiel E, Weiss A, Messerer D. Gökbuget N, et al. Among authors: rieder h. Hematol Oncol Clin North Am. 2000 Dec;14(6):1307-25, ix. doi: 10.1016/s0889-8588(05)70188-x. Hematol Oncol Clin North Am. 2000. PMID: 11147225 Review.
CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL).
Gleissner B, Goekbuget N, Rieder H, Arnold R, Schwartz S, Diedrich H, Schoch C, Heinze B, Fonatsch C, Bartram CR, Hoelzer D, Thiel E; GMALL Study Group. Gleissner B, et al. Among authors: rieder h. Blood. 2005 Dec 15;106(13):4054-6. doi: 10.1182/blood-2005-05-1866. Epub 2005 Aug 25. Blood. 2005. PMID: 16123216 Free article.
Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89.
Ludwig WD, Rieder H, Bartram CR, Heinze B, Schwartz S, Gassmann W, Löffler H, Hossfeld D, Heil G, Handt S, Heyll A, Diedrich H, Fischer K, Weiss A, Völkers B, Aydemir U, Fonatsch C, Gökbuget N, Thiel E, Hoelzer D. Ludwig WD, et al. Among authors: rieder h. Blood. 1998 Sep 15;92(6):1898-909. Blood. 1998. PMID: 9731046 Free article. Clinical Trial.
CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy.
Fischer L, Gökbuget N, Schwartz S, Burmeister T, Rieder H, Brüggemann M, Hoelzer D, Thiel E. Fischer L, et al. Among authors: rieder h. Haematologica. 2009 Feb;94(2):224-9. doi: 10.3324/haematol.13543. Epub 2008 Dec 23. Haematologica. 2009. PMID: 19109214 Free PMC article.
461 results